Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

The Associated Press June 24, 2010, 1:02PM ET

Mylan says generic of Pfizer heart drug approved

Mylan Inc. said Thursday it received Food and Drug Administration marketing approval for a generic version of Pfizer Inc.'s drug Procardia XL, which is approved to treat angina and high blood pressure.

Mylan said U.S. sales totaled $234 million in the 12 months ended March 31, according to IMS Health.

The FDA's approval includes 30 milligram, 60 milligram and 90 milligram extended-release tablets of Procardia, or nifedipine.

Mylan shares slid 8 cents to $17.71 in afternoon trading, while Pfizer stock lost 36 cents, or 2.4 percent, to $14.52.

BW Mall - Sponsored Links

Buy a link now!